fda remove semaglutide from shortage list and Tirzepatide off list: What does this mean for weight loss drug access? GLP-1 No Longer on FDA's

A 2022 study conducted in Jakarta found that the order of your food matters

However, when transitioning from Dulaglutide to Semaglutide, administered at dosages of 0.75 mg and 1 mg once a week, respectively, there was no significant difference in weight changes

Your compounding pharmacy and prescribing provider

Benge explains that pills are far less invasive than an injectable medication

There are also medical conditions where weight-loss drugs would not be recommended, including a history of medullary thyroid cancer, pancreatitis, gastroparesis, or a family history of MEN2 (multiple endocrine neoplasia syndrome type 2